- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 262313, 7 pages
Hyperthermia as Adjunct to Intravesical Chemotherapy for Bladder Cancer
Division of Urology, Duke University Medical Center, Box 2812, Durham, NC 27710, USA
Received 17 May 2013; Accepted 1 August 2013
Academic Editor: Shyh-Dar Li
Copyright © 2013 Richmond A. Owusu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- R. Siegel, C. DeSantis, K. Virgo, et al., “Cancer treatment and survivorship statistics,” Cancer Journal for Clinicians, vol. 62, no. 4, pp. 220–241, 2012.
- M. Burger, J. W. Catto, G. Dalbagni, et al., “Epidemiology and risk factors of urothelial bladder cancer,” European Urology, vol. 63, no. 2, pp. 234–241, 2013.
- M. F. Botteman, C. L. Pashos, A. Redaelli, B. Laskin, and R. Hauser, “The health economics of bladder cancer: a comprehensive review of the published literature,” PharmacoEconomics, vol. 21, no. 18, pp. 1315–1330, 2003.
- P. E. Clark, N. Agarwal, M. C. Biagioli, et al., “Bladder cancer,” Journal of the National Comprehensive Cancer Network, vol. 11, no. 4, pp. 446–475, 2013.
- M. R. Abern, R. A. Owusu, M. R. Anderson, E. N. Rampersaud, and B. A. Inman, “Perioperative intravesical chemotherapy in non-muscle-invasive bladder cancer: a systematic review and meta-analysis,” Journal of the National Comprehensive Cancer Network, vol. 11, no. 4, pp. 477–484, 2013.
- R. J. M. Lammers, J. A. Witjes, B. A. Inman et al., “The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: a systematic review,” European Urology, vol. 60, no. 1, pp. 81–93, 2011.
- W. B. Coley, “The treatment of Inoperable Sarcoma by bacterial toxins (the mixed toxins of the streptococcus erysipelas and the Bacillus prodigiosus),” Proceedings of the Royal Society of Medicine, vol. 3, pp. 1–48, 1910.
- L. R. Zacharski and V. P. Sukhatme, “Coley's toxin revisited: immunotherapy or plasminogen activator therapy of cancer?” Journal of Thrombosis and Haemostasis, vol. 3, no. 3, pp. 424–427, 2005.
- D. I. Sessler, “Thermoregulatory defense mechanisms,” Critical Care Medicine, vol. 37, no. 7, supplement, pp. S203–S210, 2009.
- E. N. Rampersaud, Z. Vujaskovic, and B. A. Inman, “Hyperthermia as a treatment for bladder cancer,” Oncology, vol. 24, no. 12, pp. 1149–1155, 2010.
- O. S. Selawry, M. N. Goldstein, and C. T. Mc, “Hyperthermia in tissue-cultured cells of malignant origin,” Cancer Research, vol. 17, no. 8, pp. 785–791, 1957.
- B. Hildebrandt, P. Wust, O. Ahlers et al., “The cellular and molecular basis of hyperthermia,” Critical Reviews in Oncology/Hematology, vol. 43, no. 1, pp. 33–56, 2002.
- R. A. Coss, W. C. Dewey, and J. R. Bamburg, “Effects of hyperthermia on dividing Chinese hamster ovary cells and on microtubules in vitro,” Cancer Research, vol. 42, no. 3, pp. 1059–1071, 1982.
- M. Jäättelä, “Heat shock proteins as cellular lifeguards,” Annals of Medicine, vol. 31, no. 4, pp. 261–271, 1999.
- B. Eppink, P. M. Krawczyk, J. Stap, and R. Kanaar, “Hyperthermia-induced DNA repair deficiency suggests novel therapeutic anti-cancer strategies,” International Journal of Hyperthermia, vol. 28, no. 6, pp. 509–517, 2012.
- W. C. Dewey, A. Westra, H. H. Miller, and H. Nagasawa, “Heat-induced lethality and chromosomal damage in synchronized Chinese hamster cells treated with 5-bromodeoxyuridine,” International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine, vol. 20, no. 6, pp. 505–520, 1971.
- M. J. Kluger, “The evolution and adaptive value of fever,” American Scientist, vol. 66, no. 1, pp. 38–43, 1978.
- B. Frey, E. M. Weiss, Y. Rubner et al., “Old and new facts about hyperthermia-induced modulations of the immune system,” International Journal of Hyperthermia, vol. 28, no. 6, pp. 528–542, 2012.
- R. J. Binder and P. K. Srivastava, “Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cells,” Nature Immunology, vol. 6, no. 6, pp. 593–599, 2005.
- P. Srivastava, “Roles of heat-shock proteins in innate and adaptive immunity,” Nature Reviews Immunology, vol. 2, no. 3, pp. 185–194, 2002.
- P. Srivastava, “Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses,” Annual Review of Immunology, vol. 20, pp. 395–425, 2002.
- H. I. Robins, M. Kutz, G. J. Wiedemann et al., “Cytokine induction by 41.8°C whole body hyperthermia,” Cancer Letters, vol. 97, no. 2, pp. 195–201, 1995.
- Q. Chen, D. T. Fisher, K. A. Clancy et al., “Fever-range thermal stress promotes lymphocyte trafficking across high endothelial venules via an interleukin 6 trans-signaling mechanism,” Nature Immunology, vol. 7, no. 12, pp. 1299–1308, 2006.
- B. E. Dayanc, S. H. Beachy, J. R. Ostberg, and E. A. Repasky, “Dissecting the role of hyperthermia in natural killer cell mediated anti-tumor responses,” International Journal of Hyperthermia, vol. 24, no. 1, pp. 41–56, 2008.
- E. D. Strauch, D. F. Fabian, J. Turner, and A. T. Lefor, “Combined hyperthermia and immunotherapy treatment of multiple pulmonary metastases in mice,” Surgical Oncology, vol. 3, no. 1, pp. 45–52, 1994.
- K. Iwata, A. Shakil, W. J. Hur, C. M. Makepeace, R. J. Griffin, and C. W. Song, “Tumour pO2 can be increased markedly by mild hyperthermia,” The British Journal of Cancer, Supplement, vol. 27, pp. S217–S221, 1996.
- X. Sun, L. Xing, C. Clifton Ling, and G. C. Li, “The effect of mild temperature hyperthermia on tumour hypoxia and blood perfusion: relevance for radiotherapy, vascular targeting and imaging,” International Journal of Hyperthermia, vol. 26, no. 3, pp. 224–231, 2010.
- P. Vaupel, F. Kallinowski, and M. Kluge, “Pathophysiology of tumors in hyperthermia,” Recent Results in Cancer Research, vol. 107, pp. 65–75, 1988.
- R. Colombo, A. Lev, L. F. Da Pozzo, M. Freschi, G. Gallus, and P. Rigatti, “A new approach using local combined microwave hyperthermia and chemotherapy in superficial transitional bladder carcinoma treatment,” Journal of Urology, vol. 153, no. 3, pp. 959–963, 1995.
- J. Van Der Zee, D. González González, G. C. Van Rhoon, J. D. P. Van Dijk, W. L. J. Van Putten, and A. A. M. Hart, “Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial,” The Lancet, vol. 355, no. 9210, pp. 1119–1125, 2000.
- M. Wittlinger, C. M. Rödel, C. Weiss et al., “Quadrimodal treatment of high-risk T1 and T2 bladder cancer: transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia,” Radiotherapy and Oncology, vol. 93, no. 2, pp. 358–363, 2009.
- J. D. P. Van Dijk, C. Schneider, R. Van Os, L. E. C. M. Blank, and D. G. Gonzalez, “Results of deep body hyperthermia with large waveguide radiators,” Advances in Experimental Medicine and Biology, vol. 267, pp. 315–319, 1990.
- J. Crezee, P. M. A. Van Haaren, H. Westendorp et al., “Improving locoregional hyperthermia delivery using the 3-D controlled AMC-8 phased array hyperthermia system: a preclinical study,” International Journal of Hyperthermia, vol. 25, no. 7, pp. 581–592, 2009.
- M. De Greef, H. P. Kok, A. Bel, and J. Crezee, “3D versus 2D steering in patient anatomies: a comparison using hyperthermia treatment planning,” International Journal of Hyperthermia, vol. 27, no. 1, pp. 74–85, 2011.
- T. V. Samulski, W. J. Grant, J. R. Oleson et al., “Clinical experience with a multi-element ultrasonic hyperthermia system: analysis of treatment temperatures,” International Journal of Hyperthermia, vol. 6, no. 5, pp. 909–922, 1990.
- G. K. Ogilvie, H. A. Reynolds, B. C. Richardson, C. W. Badger, S. A. Goss, and E. C. Burdette, “Performance of a multi-sector ultrasound hyperthermia applicator and control system: in vivo studies,” International Journal of Hyperthermia, vol. 6, no. 3, pp. 697–705, 1990.
- R. Engelhardt, “Rational for clinical application of hyperthermia and drugs,” Revista Medico-Chirurgicala a Societatii de Medici si Naturalisti din Iasi, vol. 91, no. 2, pp. 347–352, 1987.
- R. Engelhardt, “Hyperthermia and drugs,” Recent Results in Cancer Research, vol. 104, pp. 136–203, 1987.
- R. A. Vertrees, G. C. Das, V. L. Popov et al., “Synergistic interaction of hyperthermia and gemcitabine in lung cancer,” Cancer Biology and Therapy, vol. 4, no. 10, pp. 1144–1153, 2005.
- A. G. Van Der Heijden, G. Verhaegh, C. F. J. Jansen, J. A. Schalken, and J. A. Witjes, “Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: an in vitro study,” Journal of Urology, vol. 173, no. 4, pp. 1375–1380, 2005.
- F. W. Longo, P. Tomashefsky, B. D. Rivin, and M. Tannenbaum, “Interaction of ultrasonic hyperthermia with two alkylating agents in a murine bladder tumor,” Cancer Research, vol. 43, no. 7, pp. 3231–3235, 1983.
- Z. Vujaskovic and C. W. Song, “Physiological mechanisms underlying heat-induced radiosensitization,” International Journal of Hyperthermia, vol. 20, no. 2, pp. 163–174, 2004.
- M. R. Horsman and J. Overgaard, “Hyperthermia: a potent enhancer of radiotherapy,” Clinical Oncology, vol. 19, no. 6, pp. 418–426, 2007.
- R. D. Issels, “Hyperthermia adds to chemotherapy,” European Journal of Cancer, vol. 44, no. 17, pp. 2546–2554, 2008.
- Y. P. Istomin, E. A. Zhavrid, E. N. Alexandrova, O. P. Sergeyeva, and S. V. Petrovich, “Dose enhancement effect of anticaner drugs associated with increased temperature in vitro,” Experimental Oncology, vol. 30, no. 1, pp. 56–59, 2008.
- R. Paroni, A. Salonia, A. Lev et al., “Effect of local hyperthermia of the bladder on mitomycin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma,” The British Journal of Clinical Pharmacology, Supplement, vol. 52, no. 3, pp. 273–278, 2001.
- M. C. Hall, S. S. Chang, G. Dalbagni et al., “Guideline for the management of nonmuscle invasive bladder cancer (Stages Ta, T1, and Tis): 2007 update,” Journal of Urology, vol. 178, no. 6, pp. 2314–2330, 2007.
- R. Colombo, A. Salonia, Z. Leib, M. Pavone-Macaluso, and D. Engelstein, “Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC),” BJU International, vol. 107, no. 6, pp. 912–918, 2011.
- M. L. Immordino, F. Dosio, and L. Cattel, “Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential,” International Journal of Nanomedicine, vol. 1, no. 3, pp. 297–315, 2006.
- H.-I. Chang and M.-K. Yeh, “Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy,” International Journal of Nanomedicine, vol. 7, pp. 49–60, 2012.
- X. Zhang, P. F. Luckham, A. D. Hughes, S. Thom, and X. Y. Xu, “Towards an understanding of the release behavior of temperature-sensitive liposomes: a possible explanation of the, “pseudoequilibrium” release behavior at the phase transition temperature,” Journal of Liposome Research, vol. 23, no. 3, pp. 167–173, 2013.
- W. T. Al-Jamal, Z. S. Al-Ahmady, and K. Kostarelos, “Pharmacokinetics & tissue distribution of temperature-sensitive liposomal doxorubicin in tumor-bearing mice triggered with mild hyperthermia,” Biomaterials, vol. 33, no. 18, pp. 4608–4617, 2012.
- A. Gasselhuber, M. R. Dreher, A. Partanen et al., “Targeted drug delivery by high intensity focused ultrasound mediated hyperthermia combined with temperature-sensitive liposomes: computational modelling and preliminary in vivo validation,” International Journal of Hyperthermia, vol. 28, no. 4, pp. 337–348, 2012.
- A. Partanen, P. S. Yarmolenko, A. Viitala, et al., “Mild hyperthermia with magnetic resonance-guided high-intensity focused ultrasound for applications in drug delivery,” International Journal of Hyperthermia, vol. 28, no. 4, pp. 320–336, 2012.
- A. Ranjan, G. C. Jacobs, D. L. Woods et al., “Image-guided drug delivery with magnetic resonance guided high intensity focused ultrasound and temperature sensitive liposomes in a rabbit Vx2 tumor model,” Journal of Controlled Release, vol. 158, no. 3, pp. 487–494, 2012.
- M. de Smet, S. Langereis, S. van den Bosch et al., “SPECT/CT imaging of temperature-sensitive liposomes for MR-image guided drug delivery with high intensity focused ultrasound,” Journal of Controlled Release, vol. 169, pp. 182–290, 2013.
- A. A. Manzoor, L. H. Lindner, C. D. Landon, et al., “Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors,” Cancer Research, vol. 72, no. 21, pp. 5566–5575, 2012.
- T. Ta and T. M. Porter, “Thermosensitive liposomes for localized delivery and triggered release of chemotherapy,” Journal of Controlled Release, vol. 169, pp. 1112–2125, 2013.
- H. Grüll and S. Langereis, “Hyperthermia-triggered drug delivery from temperature-sensitive liposomes using MRI-guided high intensity focused ultrasound,” Journal of Controlled Release, vol. 161, no. 2, pp. 317–327, 2012.